Mid-term results of open aortic valvotomy for infants with critical aortic stenosis: seven-year experience including

Junichi Koizumi1, Kozo Ishino, Masaaki Kawada

  • 1Department of Cardiovascular Surgery, Okayama University Hospital, Okayama, Japan.

The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai Zasshi
|December 21, 2005
PubMed

Insights

Open aortic valvotomy (OAV) effectively treats critical aortic stenosis in infants, with no deaths and minimal complications. A delayed Ross procedure is a promising option for recurrent stenosis.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Cardiac Surgery

Background:

  • Critical aortic stenosis (AS) in infants presents a significant therapeutic challenge.
  • Open aortic valvotomy (OAV) is a potential intervention for this condition.

Purpose of the Study:

  • To report short- and mid-term outcomes of OAV in infants with critical AS.
  • To evaluate the efficacy and safety of OAV as an initial treatment.

Main Methods:

  • Retrospective analysis of 6 infants undergoing OAV between 1993 and 1996.
  • Procedure involved valvular commissurotomy and nodule excision under cardiopulmonary bypass.
  • Patient demographics and pre/post-operative hemodynamic data were recorded.

Main Results:

  • No early or late mortality was observed.
  • Mean aortic pressure gradient significantly decreased post-OAV (79 mmHg to 33 mmHg).
  • Three patients required reintervention for recurrent stenosis, with two later undergoing the Ross procedure.

Conclusions:

  • OAV is an effective and safe initial treatment for critical AS in infants.
  • A strategy of initial OAV followed by a delayed Ross procedure for recurrence shows promise.
  • This approach offers a viable therapeutic option for critical AS in this population.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...